Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs

By Jeannie O'Sullivan · February 22, 2022, 4:29 PM EST

Two nonprofits have been added to a sweeping antitrust lawsuit accusing Celgene Corp. and parent Bristol-Myers Squibb Co. of stifling generic competition for two blockbuster cancer drugs and driving up prices...

To view the full article, register now.